Still can't really see past the elephant of, despite the extraordinary science such low volumes traded and no big biotech experts/funds buying large on market over extended periods. Raises a red flag for me of potential weakness (not the science) they might see?
Or it could be they are late to the party for various reasons?
Seems odd though.
GLTA.
IMU Price at posting:
13.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)